Over two-thirds of healthcare organizations say precision medicine is already having a measurable effect on patient outcomes, according to a new study from Oxford Economics and SAP. The research study includes a survey of 120 healthcare professionals from research, life sciences, and healthcare organizations in North America and Europe, along with in-depth interviews with experts in the field. The report highlights what healthcare and pharmaceutical organizations are doing to accelerate the
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
Intermountain, Stanford Form Clinical Genomics Partnership to Advance Precision Medicine
Intermountain Healthcare and the Stanford Genome Technology Center (SGTC) are teaming up on a new collaborative research program focused on scientific advances in precision health and medicine. The joint research team will be composed of members of Stanford Genome Technology Center (SGTC) and the Precision Genomics Core Laboratory. Together, the joint team of researchers, clinicians and other experts will work on solving clinical issues for patients using cutting-edge technologies that enable
Read More
Report: Precision Medicine Market to Reach $88B by 2022
The global precision market is expected to reach to $88 billion by 2022 at an estimated CAGR of 12.60% from 2015 to 2022 with North America and Europe emerging as leaders, according to Global Precision Medicine Market -- Estimation & Forecast (2015-2022) report. This is led by President Obama's recent announcement to request $1B for fund the Cancer 'Moonshot' initiative for researchers to accelerate the development of new cancer detection and treatments. Presently, the main focus of the
Read More
What is the Relationship Between Precision Medicine & Predictive Analytics?
Editor's Note: Prakash Menon is the CEO at Basehealth, a science and technology leader that adds genomic precision to predictive analytics and population health management.
Let’s not bury the lead. It’s finally possible to effectively model diseases and predict risk, based on an individual’s unique clinical, lifestyle, environmental and genetic data. True predictive analytics for healthcare have arrived at long last.
Back to The Future
Historical medical information that resides in
Read More
Syapse Raises $25M to Transform Patient Care Through Precision Medicine
Syapse, a Palo Alto, CA-based company enabling healthcare systems to implement precision medicine programs has raised $25 million in Series C funding led by Ascension Ventures, a subsidiary of Ascension, the nation's largest non-profit and Catholic health system. Existing investors Social Capital Partnership and Safeguard Scientifics also participated in this new funding round. The company will use this funding round to drive the rapid expansion of its Syapse Precision Medicine
Read More
Assurex Health Nabs $15M for Precision Medicine for Behavioral Health
Assurex Health, Inc., a commercial-stage, informatics-based precision medicine company providing treatment decision support to healthcare providers for behavioral health and chronic pain conditions, has secured an additional $15 million in equity funding.
Assurex Health’s proprietary technology is based on pharmacogenomics— the study of the genetic factors that influence an individual’s response to drug treatments—as well as evidence-based medicine and clinical pharmacology. The GeneSight
Read More
Meaningful Use Stage 3 Proposed Rule: 5 Takeaways for Physicians
On March 20, 2015 the stars aligned to produce four simultaneous events that will never again coincide during the life of human civilization. The first three, the vernal equinox, a total solar eclipse and a new supermoon, were brought to us by the stars themselves, and the fourth one was thrown out there by the government. The regulations for Meaningful Use Stage 3 were finally published. Meaningful use of electronic health records (EHR) was presented to us back in 2009 as part of a stimulus
Read More
